Indivior Pharmaceuticals
INDV
INDV
76 hedge funds and large institutions have $1.04B invested in Indivior Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
46% less capital invested
Capital invested by funds: $1.91B → $1.04B (-$876M)
Holders
76
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$48.4M | |
| 2 | +$10.8M | |
| 3 | +$6.14M | |
| 4 |
LIM
Lingotto Investment Management
London,
United Kingdom
|
+$5.62M |
| 5 |
Citigroup
New York
|
+$3.01M |
Top Sellers
| 1 | -$71.7M | |
| 2 | -$60.5M | |
| 3 | -$27.8M | |
| 4 |
Goldman Sachs
New York
|
-$21.7M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$11.3M |